Wm. Duan et al., Survival of intrastriatal xenografts of ventral mesencephalic dopamine neurons from MHC-deficient mice to adult rats, EXP NEUROL, 167(1), 2001, pp. 108-117
Previous studies of neural xenografts have used immunosuppressive agents to
prevent graft rejection. In the present study we have examined the surviva
l of mouse dopamine neurons lacking either MHC class I or MHC class II mole
cules transplanted into rat brains and the host immune and inflammatory res
ponses against the xenografts. Survival of neural grafts was immunocytochem
ically determined at 4 days, 2 weeks, and 6 weeks after transplantation by
counting tyrosine hydroxylase (TH)-positive cells in the graft areas. In ad
dition, the host immune and inflammatory responses against neural xenograft
s were evaluated by semiquantitatively rating MHC class I and class II: ant
igen expression, accumulation of macrophages and activated microglia, and i
nfiltration of CD4- and CD8-positive T-lymphocytes. For the negative contro
ls, the mean number of TH-positive cells in rats that received wild-type mo
use tissue progressively decreased at various time periods following transp
lantation. In contrast, intrastriatal grafting of either MHC class I or MHC
class II antigen-depleted neural xenografts resulted in a prolonged surviv
al and were comparable to cyclosporin A-treated rats that had received wild
-type mouse tissue. These results indicate that genetically modified donor
tissue lacking MHC molecules can be used to prevent neural xenograft reject
ion. (C) 2001 Academic Press.